New diabetes clinical trial: A Study of IBI362 in Participants With Type 2 Diabetes

Published on: November 07, 2022 at 11:00AM
Condition:   Type 2 Diabetes
Interventions:   Drug: dulaglutide;   Drug: IBI362
Sponsor:   Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting
https://ift.tt/4IlfUh0